The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group study JCOG1017.
 
Tadahiko Shien
Consulting or Advisory Role - Allergan; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin; Lilly; Novartis; Pfizer; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Allergan; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin; Lilly; Nihonkayaku; Novartis; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - Eisai (Inst); Nihonkayaku (Inst)
 
Fumikata Hara
Honoraria - Chugai Pharma; Daiichi Sankyo; Kyowa Kirin; Lilly Japan; Pfizer; Taiho Pharmaceutical
 
Kenjiro Aogi
Honoraria - AstraZeneca; Becton Dickinson; Chugai Pharma; Daiichi Sankyo/UCB Japan; Eisai; Lilly; Mochida Pharmaceutical Co. Ltd.; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Terumo
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Chugai Pharma; Eisai
 
Yasuhiro Yanagita
No Relationships to Disclose
 
Michiko Tsuneizumi
No Relationships to Disclose
 
Naohito Yamamoto
Research Funding - AstraZeneca; Chugai Pharma; Lilly O.; MSD; Pfizer
 
Hiroshi Matsumoto
No Relationships to Disclose
 
Akihiko Suto
No Relationships to Disclose
 
Kenichi Watanabe
No Relationships to Disclose
 
Michiko Harao
No Relationships to Disclose
 
Chizuko Kanbayashi
No Relationships to Disclose
 
Mitsuya Ito
No Relationships to Disclose
 
Takayuki Kadoya
No Relationships to Disclose
 
Keisei Anan
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Lilly Japan; Novartis; Pfizer; Taiho Pharmaceutical
 
Shigeto Maeda
Research Funding - Eisai (Inst)
 
Keita Sasaki
No Relationships to Disclose
 
Gakuto Ogawa
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - m3.com
 
Hiroji Iwata
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Lilly Japan; MSD; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly Japan; MSD; Novartis; Pfizer; Sanofi
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); MSD (Inst); Nihonkayaku (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)